๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Reduction of synonymous substitutions in the core protein gene of hepatitis C virus

โœ Scribed by Yasuo Ina; Masashi Mizokami; Kenichi Ohba; Takashi Gojobori


Book ID
104652284
Publisher
Springer
Year
1994
Tongue
English
Weight
690 KB
Volume
38
Category
Article
ISSN
0022-2844

No coin nor oath required. For personal study only.

โœฆ Synopsis


Molecular evolutionary analyses were carried out to elucidate the phylogenetic relationships, the evolutionary rate, and the divergence times of hepatitis C viruses. Using the nucleotide sequences of the viruses isolated from various locations in the world, we constructed phylogenetic trees. The trees showed that strains isolated from a single location were not necessarily clustered as a group. This suggests that the viruses may be transferred with blood on a worldwide scale. We estimated the evolutionary rates at synonymous and nonsynonymous sites for all genes in the viral genome. We then found that the rate (1.35 x 10 .3 per site per year) at synonymous sites for the C gene was much smaller than those for the other genes (e.g., 6.29 x 10 -3 per site per year for the E gene). This indicates that a special type of functional constraint on synonymous substitutions may exist in the C gene. Because we found an open reading frame (ORF) with the C gene region, the possibility exists that synonymous substitutions for the C gene are constrained by the overlapping ORF whose reading frame is different from that of the C gene. Applying the evolutionary rates to the trees, we also suggest that major groups of hepatitis C viruses diverged from their common ancestor several hundred years ago.


๐Ÿ“œ SIMILAR VOLUMES


Amino acid substitutions in the hepatiti
โœ Norio Akuta; Fumitaka Suzuki; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Yo ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 161 KB ๐Ÿ‘ 2 views

We showed previously that amino acid (aa) substitutions in hepatitis C virus core region (HCV-CR) are negative predictors of virologic response to pegylated interferon (IFN) plus ribavirin therapy. HCV-CR induces hepatocellular carcinoma in transgenic mice, but the clinical impact is still unclear.